• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶25(MT6-基质金属蛋白酶)在人类结肠癌中高表达,促进肿瘤生长,并具有独特的生化特性。

MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties.

作者信息

Sun Qing, Weber Christopher R, Sohail Anjum, Bernardo M Margarida, Toth Marta, Zhao Huiren, Turner Jerrold R, Fridman Rafael

机构信息

Department of Pathology and Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

出版信息

J Biol Chem. 2007 Jul 27;282(30):21998-2010. doi: 10.1074/jbc.M701737200. Epub 2007 May 18.

DOI:10.1074/jbc.M701737200
PMID:17513868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1978545/
Abstract

MMP25 (MT6-MMP) is one of the two glycosylphosphatidylinositol-anchored matrix metalloproteinases (MMPs) that have been suggested to play a role in pericellular proteolysis. However, its role in cancer is unknown, and its biochemical properties are not well established. Here we found a marked increase in MT6-MMP expression within in situ dysplasia and invasive cancer in 61 samples of human colon cancer. Expression of MT6-MMP in HCT-116 human colon cancer cells promoted tumori-genesis in nude mice. Histologically, the MT6-MMP-expressing tumors demonstrated an infiltrative leading edge in contrast to a rounded leading edge in vector control tumors. Biochemical and biosynthesis analyses revealed that MT6-MMP displayed on the cell surface exists as a major form of 120 kDa that likely represents enzyme homodimers linked by disulfide bonds. Upon reduction, a single 57-kDa active MT6-MMP was detected. Interestingly, neither membrane-anchored nor phosphatidylinositol-specific phospholipase C-released MT6-MMPs were found to be associated with tissue inhibitor of metalloproteinases (TIMPs) and did not activate pro-gelatinases (pro-MMP-2 and pro-MMP-9) even in the presence of exogenous TIMP-2 or TIMP-1. A catalytic domain of MT6-MMP was inhibited preferentially by TIMP-1 (K(i) = 0.2 nm) over TIMP-2 (K(i) = 2.0 nm), because of a slower association rate. These results show that MT6-MMP may play a role in colon cancer and exhibit unique biochemical and structural properties that may regulate proteolytic function at the cell surface.

摘要

MMP25(MT6-MMP)是两种糖基磷脂酰肌醇锚定的基质金属蛋白酶(MMP)之一,有人认为它在细胞周围蛋白水解中发挥作用。然而,其在癌症中的作用尚不清楚,其生化特性也未完全明确。在此,我们发现61例人类结肠癌原位发育异常和浸润性癌组织中MT6-MMP表达显著增加。HCT-116人结肠癌细胞中MT6-MMP的表达促进了裸鼠体内肿瘤的发生。组织学上,与载体对照肿瘤的圆形前缘相比,表达MT6-MMP的肿瘤显示出浸润性前缘。生化和生物合成分析表明,细胞表面展示的MT6-MMP主要以120 kDa的形式存在,可能代表通过二硫键连接的酶同二聚体。还原后,检测到单一的57 kDa活性MT6-MMP。有趣的是,无论是膜锚定的还是磷脂酰肌醇特异性磷脂酶C释放的MT6-MMP均未发现与金属蛋白酶组织抑制剂(TIMP)相关,即使在存在外源性TIMP-2或TIMP-1的情况下也不激活前明胶酶(前MMP-2和前MMP-9)。由于结合速率较慢,MT6-MMP的催化结构域被TIMP-1(K(i)=0.2 nm)优先抑制,而不是TIMP-2(K(i)=2.0 nm)。这些结果表明,MT6-MMP可能在结肠癌中发挥作用,并表现出独特的生化和结构特性,可能在细胞表面调节蛋白水解功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/0301b7a7ab48/nihms-27651-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/fad17efb2029/nihms-27651-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/4e78d5dc8612/nihms-27651-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/d59e8972ed9d/nihms-27651-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/cb6d8e8fef8f/nihms-27651-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/64282fd686ca/nihms-27651-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/347d718af16e/nihms-27651-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/0301b7a7ab48/nihms-27651-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/fad17efb2029/nihms-27651-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/4e78d5dc8612/nihms-27651-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/d59e8972ed9d/nihms-27651-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/cb6d8e8fef8f/nihms-27651-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/64282fd686ca/nihms-27651-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/347d718af16e/nihms-27651-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2923/1978545/0301b7a7ab48/nihms-27651-f0007.jpg

相似文献

1
MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties.基质金属蛋白酶25(MT6-基质金属蛋白酶)在人类结肠癌中高表达,促进肿瘤生长,并具有独特的生化特性。
J Biol Chem. 2007 Jul 27;282(30):21998-2010. doi: 10.1074/jbc.M701737200. Epub 2007 May 18.
2
Biochemical characterization of the cellular glycosylphosphatidylinositol-linked membrane type-6 matrix metalloproteinase.细胞糖基磷脂酰肌醇连接膜型 6 基质金属蛋白酶的生化特性分析。
J Biol Chem. 2010 May 21;285(21):16076-86. doi: 10.1074/jbc.M110.107094. Epub 2010 Mar 22.
3
Identification and role of the homodimerization interface of the glycosylphosphatidylinositol-anchored membrane type 6 matrix metalloproteinase (MMP25).糖基磷脂酰肌醇锚定膜型6基质金属蛋白酶(MMP25)同源二聚化界面的鉴定及其作用
J Biol Chem. 2008 Dec 12;283(50):35023-32. doi: 10.1074/jbc.M806553200. Epub 2008 Oct 20.
4
Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP.膜型6基质金属蛋白酶(MT6-MMP,MMP-25)是第二种糖基磷脂酰肌醇(GPI)锚定的基质金属蛋白酶。
FEBS Lett. 2000 Sep 1;480(2-3):142-6. doi: 10.1016/s0014-5793(00)01919-0.
5
Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities.白细胞溶素(膜型 6 基质金属蛋白酶 25,MMP25)的生化特征和 N 端组学分析:趋化因子和波形蛋白的裂解增强了细胞迁移和巨噬细胞吞噬活性。
J Biol Chem. 2012 Apr 13;287(16):13382-95. doi: 10.1074/jbc.M111.314179. Epub 2012 Feb 24.
6
MT6-MMP is present in lipid rafts and faces inward in living human PMNs but translocates to the cell surface during neutrophil apoptosis.MT6-MMP 存在于脂筏中,在活的人嗜中性粒细胞中面向细胞内,但在嗜中性粒细胞凋亡过程中向细胞表面易位。
Int Immunol. 2010 Aug;22(8):637-49. doi: 10.1093/intimm/dxq048. Epub 2010 May 25.
7
MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.MT4-(基质金属蛋白酶17)和MT6-基质金属蛋白酶(基质金属蛋白酶25):一组独特的膜锚定基质金属蛋白酶:特性及其在癌症中的表达
Cancer Metastasis Rev. 2008 Jun;27(2):289-302. doi: 10.1007/s10555-008-9129-8.
8
Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils.聚集素是一种丰富的血清因子,可能是中性粒细胞产生的MT6-MMP/MMP-25的负调节因子。
J Biol Chem. 2003 Sep 19;278(38):36350-7. doi: 10.1074/jbc.M301509200. Epub 2003 Jul 14.
9
Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.人MT6-基质金属蛋白酶:鉴定、前明胶酶A激活及在脑肿瘤中的表达。
Cancer Res. 2000 Feb 15;60(4):877-82.
10
Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.白细胞溶素/膜型6基质金属蛋白酶/基质金属蛋白酶25在天冬酰胺(109)-酪氨酸键处对前基质金属蛋白酶-2的直接激活作用。
Cancer Res. 2003 Oct 15;63(20):6758-62.

引用本文的文献

1
Modulation of the malignant behavior of tongue squamous cell carcinoma cells by matrix metallopeptidase 25 through the NF-κB pathway.基质金属肽酶25通过NF-κB途径对舌鳞状细胞癌细胞恶性行为的调控
Histol Histopathol. 2025 Aug;40(8):1261-1274. doi: 10.14670/HH-18-852. Epub 2024 Nov 25.
2
Elevated Plasma Levels of MT4-MMP and MT6-MMP; A New Observation in Patients with Thyroid Nodules.MT4-MMP和MT6-MMP血浆水平升高:甲状腺结节患者的新观察结果
Arch Iran Med. 2023 Jun 1;26(6):338-345. doi: 10.34172/aim.2023.51.
3
Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer.

本文引用的文献

1
MT1-MMP shedding involves an ADAM and is independent of its localization in lipid rafts.MT1 - 基质金属蛋白酶的脱落涉及一种解聚素和金属蛋白酶结构域蛋白(ADAM),且与其在脂筏中的定位无关。
Biochem Biophys Res Commun. 2006 Nov 17;350(2):377-84. doi: 10.1016/j.bbrc.2006.09.052. Epub 2006 Sep 22.
2
A cancer cell metalloprotease triad regulates the basement membrane transmigration program.一种癌细胞金属蛋白酶三联体调控基底膜迁移程序。
Genes Dev. 2006 Oct 1;20(19):2673-86. doi: 10.1101/gad.1451806. Epub 2006 Sep 18.
3
Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.
基质金属蛋白酶作为结肠炎相关癌症的生物标志物和治疗靶点。
Front Oncol. 2024 Jan 15;13:1325095. doi: 10.3389/fonc.2023.1325095. eCollection 2023.
4
Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play.基质金属蛋白酶及其抑制剂在肺纤维化中的作用:EMMPRIN/CD147 开始发挥作用。
Int J Mol Sci. 2022 Jun 21;23(13):6894. doi: 10.3390/ijms23136894.
5
Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer.关键的基质重塑酶:在癌症中的功能及靶向作用
Cancers (Basel). 2021 Mar 22;13(6):1441. doi: 10.3390/cancers13061441.
6
MMP25 Regulates Immune Infiltration Level and Survival Outcome in Head and Neck Cancer Patients.基质金属蛋白酶25调节头颈癌患者的免疫浸润水平和生存结局。
Front Oncol. 2020 Jul 29;10:1088. doi: 10.3389/fonc.2020.01088. eCollection 2020.
7
Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and Its Relation to Epigenomic Subtypes and HER2 Overexpression.乳腺癌中基质金属蛋白酶基因启动子区域CpG二核苷酸的异常高甲基化及其与表观基因组亚型和HER2过表达的关系
Biomedicines. 2020 May 10;8(5):116. doi: 10.3390/biomedicines8050116.
8
Role of Matrix Metalloproteinases in Angiogenesis and Cancer.基质金属蛋白酶在血管生成和癌症中的作用。
Front Oncol. 2019 Dec 6;9:1370. doi: 10.3389/fonc.2019.01370. eCollection 2019.
9
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.基质金属蛋白酶在肝癌上皮-间质转化中的作用。
Anal Cell Pathol (Amst). 2019 Nov 26;2019:9423907. doi: 10.1155/2019/9423907. eCollection 2019.
10
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.基质金属蛋白酶(MMP)基因表达谱的泛癌分析及其诊断/预后潜力。
BMC Cancer. 2019 Jun 14;19(1):581. doi: 10.1186/s12885-019-5768-0.
膜型4基质金属蛋白酶促进乳腺癌生长和转移。
Cancer Res. 2006 May 15;66(10):5165-72. doi: 10.1158/0008-5472.CAN-05-3012.
4
Matrix metalloproteinases and tumor metastasis.基质金属蛋白酶与肿瘤转移
Cancer Metastasis Rev. 2006 Mar;25(1):9-34. doi: 10.1007/s10555-006-7886-9.
5
Individual Timp deficiencies differentially impact pro-MMP-2 activation.个体组织金属蛋白酶抑制因子(TIMP)缺陷对前基质金属蛋白酶-2(pro-MMP-2)的激活有不同影响。
J Biol Chem. 2006 Apr 14;281(15):10337-46. doi: 10.1074/jbc.M512009200. Epub 2006 Feb 9.
6
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.尿路上皮癌中基质金属蛋白酶的综合分析与定位
Br J Cancer. 2006 Feb 27;94(4):569-77. doi: 10.1038/sj.bjc.6602931.
7
Structure and function of matrix metalloproteinases and TIMPs.基质金属蛋白酶和金属蛋白酶组织抑制因子的结构与功能
Cardiovasc Res. 2006 Feb 15;69(3):562-73. doi: 10.1016/j.cardiores.2005.12.002. Epub 2006 Jan 5.
8
Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury.胸腺素β4调节碱烧伤后角膜基质金属蛋白酶水平及多形核细胞浸润。
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2388-95. doi: 10.1167/iovs.04-1368.
9
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues.通过人前列腺组织的表达分析鉴定与前列腺癌进展相关的降解组成分。
Br J Cancer. 2005 Jun 20;92(12):2171-80. doi: 10.1038/sj.bjc.6602630.
10
Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6.中性粒细胞特异性白细胞溶素/膜型基质金属蛋白酶6对α-1-蛋白酶抑制剂的快速失活作用
Exp Cell Res. 2004 Jun 10;296(2):145-50. doi: 10.1016/j.yexcr.2004.02.008.